apalutamide will minimize the level or influence of ethinylestradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay clear of or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with drugs which might be CYP3A4 substrates can lead to lower exposure to thes